technetium tc 99m hydroxymethylene diphosphonate has been researched along with Ventricular Dysfunction, Left in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashino, H; Kawakami, H; Matsuoka, H; Miyagawa, M; Mochizuki, T; Nagao, M; Tokunaga, N; Uemura, M | 1 |
1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Evaluation of acute myocardial infarction with late enhancement pattern on MRI compared with 201Tl and 99mTc-hydroxymethylenediphosphonate (HMDP) dual single photon emission computed tomography (SPECT) images.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Medronate; Thallium; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2007 |